US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
イギリス
LSE
Exacompta Clairefontaine (0FOA) 銘柄情報

Exacompta Clairefontaine (0FOA)

137.00

0.00

(0.00%)

終了 7月10日 12:30AM

Exacompta Clairefontaine (0FOA) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

137.00

( - )

買値

137.00

売値

137.00

出来高

0.00

平均取引量 (3 か月)

21 €

財務取引量

-

0.00 日の範囲 0.00

137.00 52 週間の範囲 137.00

時価総額

企業価値

181.815M

前日終値

137.00

始値

-

時刻

最終取引時間

VWAP

-

歳入

802.45M

純利益

21.62M

発行済株式数

1,131,480

浮動株比率 (%)

19.54%

機関投資家保有比率 (%)

-

配当利回り

7.1 (4.38%)

PER

8.53

株価売上高倍率 (PSR)

0.23

1 株当たり利益 (EPS)

19.11

ベータ

0.19

Exacompta Clairefontaine S.A. engages in producing, finishing, and formatting of papers in France, Europe, and internationally. It operates through Paper and Processing segments. The company manufactures diary and personal stationery; office desks and filing items; art and leisure products; and digi... Exacompta Clairefontaine S.A. engages in producing, finishing, and formatting of papers in France, Europe, and internationally. It operates through Paper and Processing segments. The company manufactures diary and personal stationery; office desks and filing items; art and leisure products; and digital photos. It is also involved in paper shaping activities. The company was founded in 1858 and is based in Etival-Clairefontaine, France. Exacompta Clairefontaine S.A. operates as a subsidiary of Etablissements Charles Nusse. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.exacomptaclairefontaine.fr

本社

Etival-clairefontaine, France

設立

2026

Exacompta Clairefontaine is listed in the sector of the ロンドン証券取引所 with ticker 0FOA. The last closing price for Exacompta Clairefontaine was 137.00 €. Over the last year, Exacompta Clairefontaine shares have traded in a share price range of 137.00 € to 137.00 €.

Exacompta Clairefontaine currently has 1,131,480 shares in issue. The market capitalisation of Exacompta Clairefontaine is 155.01 € million. Exacompta Clairefontaine has a price to earnings ratio (PE ratio) of 8.53.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	137	137	137	0	0	DE
52	0	0	137	137	137	0	137	DE
156	0	0	137	137	137	0	137	DE
260	0	0	137	137	137	0	137	DE

0FOA - Frequently Asked Questions (FAQ)

What is the current Exacompta Clairefontaine share price?

The current share price of Exacompta Clairefontaine is 137.00 €

How many Exacompta Clairefontaine shares are in issue?

Exacompta Clairefontaine has 1,131,480 shares in issue

What is the market cap of Exacompta Clairefontaine?

The market capitalisation of Exacompta Clairefontaine is EUR 155.01M

What is the 1 year trading range for Exacompta Clairefontaine share price?

Exacompta Clairefontaine has traded in the range of 137.00 € to 137.00 € during the past year

What is the PE ratio of Exacompta Clairefontaine?

The price to earnings ratio of Exacompta Clairefontaine is 8.53

What is the cash to sales ratio of Exacompta Clairefontaine?

The cash to sales ratio of Exacompta Clairefontaine is 0.23

What is the registered address of Exacompta Clairefontaine?

The registered address for Exacompta Clairefontaine is 19 Rue de l'Abbaye, Etival-Clairefontaine, Lorraine, 88480

What is the Exacompta Clairefontaine website address?

The website address for Exacompta Clairefontaine is www.exacomptaclairefontaine.fr

GoldenCyclops48

GoldenCyclops48 4分前

How do you know so much or are you like so smart you don't have a life. You sure spend a lot of intellectual energy here. Boring...

MrMontag

MrMontag 4分前

Trump isn't saying anything about this or making any calls on this. His hands are plenty full. Don't be naive.

Top Penny

Top Penny 5分前

Financials are NOT fake point blank period!!!

The GidDy uP Kid

The GidDy uP Kid 5分前

VIVS… https://schrts.co/NieenYHI

The GidDy uP Kid

The GidDy uP Kid 6分前

VIVS… https://schrts.co/NieenYHI

DrivenByPain

DrivenByPain 6分前

🤑SNTX🤑 Time Bomb $🤑$ Time Bomb https://www.youtube.com/watch?v=-nFVOukrl_A

The GidDy uP Kid

The GidDy uP Kid 6分前

VIVS… https://schrts.co/NieenYHI

DavidW2

DavidW2 6分前

Anyone lives at London? can visit NWBO facility? or lives at Maryland, can visit NWBO office? to find out what is current status? This company keep silent too long and keeps dilute the shares without telling investors for any reason. I think this is very unfair to investors!

Talisman33

Talisman33 6分前

The retailer (betterhealth) they use to sell Lunar has been listing it at 40% off for at least two months now, right? How is that better than trying to sell it on the largest national retailer platform Amazon at full price with subscription discount? Sure Lunar is not their core product, but it li

ge11

Trump will make the calls from here on out. Mark Smith has little to say where NioCorp will go from here. I wish Trump had control of what these people are compensated for what they get done for their shareholders. Hopefully they make it right with their long time shareholders someday.

TieetCoolee

TieetCoolee 7分前

It didn't work 🫩😝
$FMCC~ $FNMA~ ZOMBIE STOCKS RULE!

Goats'nCrows

Goats'nCrows 8分前

I'm an 85 IQ guy who works with hydraulic fluid and axle grease, so you're going to have to help me out with what you mean.

My 150 IQ friends tell me the guy you're awarding laurels is a moron, however.

Sunnybank

Sunnybank 8分前

Yowzers-offense woke up. Thank goodness for Uncle Ben. Hope Fried comes back more consistently than Cole an Rodon. Grisham coming on. Wells and Volpe showing flashes. Defense shaky. As you say lots of parity. Dodgers definitely the cream of the crop. Phillies coming on strong. Braves doing a great Y

DrivenByPain

DrivenByPain 10分前

🤑SNTX🤑 Push It $🤑$ https://www.youtube.com/watch?v=Ps0MfBG5-Uo

goldfinger

goldfinger 10分前

When the clowns come on bashers know there days are numbered.

Aquahoya

Aquahoya 10分前

Will be interesting. Like I said, I got a message saying he will have something soon. But soon is relative. Could be next week or many many weeks from now. We all know they are looking for portfolio / partnership. Would be nice to get this over .0010 before it comes.

Doc logic

Doc logic 10分前

biotech_researcher,

Don’t worry about big pharma going down, there will be merger lifeboats for some of them. Even some of those market makers might get a life vest and the Carpathia can pick them up; ). Best wishes.

Top Penny

Top Penny 13分前

Bye bye shorty

https://investorshub.advfn.com/uimage/uploads/2025/8/12/sjgigmargin-calls-1024x576.jpg

along4zride

along4zride 14分前

How about some specifics . None is never offered. Why hasn’t (FNMA) been relisted when they have met the requirements for many months ?
Answer:
They haven’t and they won’t .Cancellation is in play .
Poster is all hat and no (FNMA) cattle.

Naught

Naught 14分前

Please ask Gemini if the receivership has ANY control over the PAC moving forward..

Doc logic

Doc logic 14分前

Goat’snCrows,

I can imagine that he’s going to look great on the witness stand while the jury is lifting their glasses of grapefruit juice to toast him; ). Best wishes.

madras50

madras50 15分前

Last 2 press releases indicate this should be well above where it is. This one for real?

biotech_researcher

biotech_researcher 15分前

This is a disaster of epic proportions…

pinhigh

pinhigh 15分前

Your anticipated BS artie! You were undoubtedly one of the kings of Biel shorters. So sorry your revenue source is drying up! LOL Go Biel!

Exacompta Clairefontaine

Deutsche Lufthansa

Genco Shipping & Trading

Hummingbird Resources

Srisawad Corporation Pub... (PK)

Bond 3.5% 24/29 Bond 3.5...

ARK Innovation UCITS ETF...

DWA MLP Select Total Ret...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。